Progress of ADAM17 in Fibrosis-Related Diseases
Fibrosis leads to structural damage and functional decline and is characterized by an accumulation of fibrous connective tissue and a reduction in parenchymal cells. Because of its extremely poor prognosis, organ fibrosis poses a significant economic burden. In order to prevent and treat fibrosis mo...
Saved in:
| Main Authors: | Suyan Yan, Yaqi Zhao, Yuyu Yang, Baocheng Liu, Wei Xu, Zhenzhen Ma, Qingrui Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/mi/9999723 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress on ADAM28 in malignant tumors
by: Lanlan Zhao, et al.
Published: (2025-04-01) -
A noval identification of 4 systemic sclerosis - interstitial lung disease subgroups using principal component analysis-based cluster analysis
by: Yaqi Zhao, et al.
Published: (2025-05-01) -
Updates on Inflammatory Molecular Pathways Mediated by ADAM17 in Autoimmunity
by: Margherita Sisto, et al.
Published: (2024-12-01) -
A disintegrin and metallopeptidase domain (ADAM) 12, ADAM 17 mRNA and ADAM10 protein hold potential as biomarkers for detection of early gastric cancer
by: Sooyeon Oh, et al.
Published: (2025-01-01) -
Inhibiting ADAM17 enhances the efficacy of olaparib in ovarian cancer spheroids
by: Christoph Rogmans, et al.
Published: (2024-11-01)